[THALIDOMIDE EMBRYOPATHY]. 1963

E KASS

UI MeSH Term Description Entries
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000015 Abnormalities, Multiple Congenital abnormalities that affect more than one organ or body structure. Multiple Abnormalities
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid

Related Publications

E KASS
January 1963, Annales paediatrici. International review of pediatrics,
E KASS
January 1963, Annales paediatrici. International review of pediatrics,
E KASS
October 1962, La Presse medicale,
E KASS
June 1962, Deutsche medizinische Wochenschrift (1946),
E KASS
August 1962, Archives of environmental health,
E KASS
March 1962, Svenska lakartidningen,
E KASS
August 1962, Orvosi hetilap,
E KASS
August 1977, Teratology,
E KASS
April 1966, British journal of experimental pathology,
E KASS
September 1968, Archiv fur Kinderheilkunde,
Copied contents to your clipboard!